Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
5.31
+0.22 (4.32%)
Aug 14, 2025, 11:37 AM - Market open
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $414.48 million as of August 14, 2025. Its market cap has decreased by -41.39% in one year.
Market Cap
414.48M
Enterprise Value
70.29M
1-Year Change
-41.39%
Ranking
Category
Stock Price
$5.31
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has decreased from $467.51M to $414.48M, a decrease of -11.34%. That is a compound annual growth rate of -1.69%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 590.09B |
| Johnson & Johnson | 418.67B |
| AbbVie | 355.59B |
| UnitedHealth Group | 243.26B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.20B |
| Novo Nordisk | 223.00B |